Key points from article :
Over 150,000 people with type 1 diabetes in England and Wales will be offered an artificial pancreas on the NHS.
The device, also called a hybrid closed-loop system, uses a hi-tech algorithm to determine insulin dosage and blood sugar levels.
Trials show it is more effective at managing diabetes than current devices and requires less input from patients.
The National Institute for Health and Care Excellence (Nice) recommends the device for those whose diabetes is not controlled by current methods.
Nice says hybrid closed-loop systems will be a game-changer for people with type 1 diabetes.
The technology will improve health and wellbeing of patients and save the NHS money in the long term.
